Funding Rounds
Beckley Psytech

Beckley Psytech Series B (2024, $40M)

Beckley Psytech

Short-duration psychedelic medicines developer for neuropsychiatric conditions.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $40.00M

Raised Date: 2024-04-01

Investors